Probiotics: A possible specific liver drug for non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is and will continue to be a major liver health issue worldwide in the coming decades. There are no leading drug candidates at this point, although there are several promising concepts in drug development. Recent studies have proposed a possible role of inte...

Full description

Saved in:
Bibliographic Details
Published in:Bioscience hypotheses 2009-01, Vol.2 (1), p.54-55
Main Authors: Zheng, Ming-Hua, Xin, Yong-Ning, Li, Hai, Cai, Xiao-Niao, Cui, Yao-Li, Qiu, Li-Xin, Chen, Yong-Ping
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Non-alcoholic fatty liver disease (NAFLD) is and will continue to be a major liver health issue worldwide in the coming decades. There are no leading drug candidates at this point, although there are several promising concepts in drug development. Recent studies have proposed a possible role of intestinal bacterial overgrowth in the development of non-alcoholic steatohepatitis, thus indicated probiotics maybe a potential specific liver drug for NAFLD in the future.
ISSN:1756-2392
DOI:10.1016/j.bihy.2008.10.004